Hostname: page-component-8448b6f56d-sxzjt Total loading time: 0 Render date: 2024-04-24T17:37:25.974Z Has data issue: false hasContentIssue false

Truth, Disclosure and the Influence of Industry on the Development of NICE Guidelines: An Interview with Tim Kendall

Published online by Cambridge University Press:  01 March 2007

Tim Kendall
Affiliation:
Fulwood House, Old Fulwood Road, Sheffield, South Yorkshire S10 2TH, UK E-mail: tim.kendall@sct.nhs.uk
Linsey McGoey
Affiliation:
BIOS, LSE, Houghton Street, London WC2A 2AE, UK E-mail: l.j.mcgoey@lse.ac.uk
Get access

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Interview
Copyright
Copyright © London School of Economics and Political Science 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Chalmers, I. (1990). Underreporting research is scientific misconduct. Journal of the American Medical Association, 263, 14051408.CrossRefGoogle ScholarPubMed
Chalmers, I. (2006). From optimism to disillusion about commitment to transparency in the medico-industrial complex. Journal of the Royal Society of Medicine, 99, 337341.CrossRefGoogle ScholarPubMed
Kendall, T. (1997). Trieste: The current situation. Plenary address, Third International Conference on Psychosis, ‘Integrating the Inner and Outer Worlds’, University of Essex.Google Scholar
Kondro, W. (2004). Drug company experts advised staff to withhold data about SSRI use in Children. Canadian Medical Association Journal, 170, 783.CrossRefGoogle ScholarPubMed
Whittington, C., Kendall, T., Fonagy, P., Cottrell, D., Cotgrove, A., & Boddington, E. (2004). Selective Serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. The Lancet, 363: 13411345.CrossRefGoogle ScholarPubMed
Whittington, C., Kendall, T., & Pilling, S. (2005). Are the SSRIs and atypical antidepressants safe and effective for children and adolescents? Current Opinions in Psychiatry, 18: 2125.Google ScholarPubMed